NanoVibronix, Inc

(NASDAQ:NAOV)

Latest On NanoVibronix, Inc (NAOV):

Date/Time Type Description Signal Details
2023-03-21 23:12 ESTNewsNanoVibronix files for US patent linked to UroShield deviceN/A
2023-03-14 23:34 ESTNewsNanoVibronix says study shows benefit of UroShield in spinal cord injury patientsN/A
2023-02-09 00:09 ESTNewsNanoVibronix falls 11% on 1-for-20 reverse stock splitN/A
2022-11-29 09:58 ESTNewsNanoVibronix jumps 93% on FDA nod for ultrasound pain therapy deviceN/A
2022-11-29 09:57 ESTNewsNanoVibronix prices $2.4M registered direct offeringN/A
2022-11-16 15:24 ESTNewsNanoVibronix announces positive results from Uroshield studyN/A
2022-10-19 11:53 ESTNewsNanoVibronix receives extension to satisfy Nasdaq bid price requirementN/A
2022-09-23 13:06 ESTNewsNanoVibronix rises 27% on approval of Uroshield for sale in UK by NHS internal supply chain contractN/A
2022-05-17 13:27 ESTNewsNanoVibronix GAAP EPS of -$0.04, revenue of $0.27MN/A
2022-05-04 09:49 ESTNewsNanoVibronix files for FDA clearance of ultrasound pain therapy device PainShield MD PlusN/A
2022-03-30 21:27 ESTNewsNanoVibronix stock soars 32% as Health Canada approves PainGuard/UroGuardN/A
2022-01-25 00:02 ESTNewsNanoVibronix extends reach of UroShield and PainShield through agreement with MedtechN/A
2022-01-19 15:31 ESTNewsNanoVibronix files three US patent leveraging acoustic wave technologyN/A
2021-10-11 15:03 ESTNewsNanoVibronix announces positive results for ultrasound device in pain studyN/A
2021-09-02 03:36 ESTNewsNanoVibronix: Portable Ultrasonic Therapeutic DevicesN/A
2021-08-16 21:56 ESTNewsNanoVibronix jumps 23% after introduction of PainShield Relief therapy for OTC useN/A
2021-08-16 21:56 ESTNewsNanoVibronix, Nymox Pharmaceutical leads healthcare gainers; Sesen Bio, ESSA Pharma among major losersN/A
2021-07-29 22:40 ESTNewsNanoVibronix shares soar on registration approval for UroShield from TGA AustraliaN/A
2021-07-23 03:43 ESTNewsNanoVibronix says positive results from UroShield study published in medical journalN/A
2021-04-05 12:22 ESTNewsTSLA, NVTA, CHPT and NNOX among premarket gainersN/A
2021-01-06 16:16 ESTFinancialsCompany financials have been released.Neutral
2020-12-12 02:46 ESTNewsNanoVibronix announces expansion of distribution pact for its ultrasound devicesN/A
2020-12-03 03:58 ESTNewsNanoVibronix rockets 133% on UroShield benefit in urinary tract infectionsN/A
2020-12-03 03:57 ESTNewsNanoVibronix secures $6M in equity capitalN/A
2020-11-26 20:55 ESTFinancialsCompany financials have been released.Neutral
2020-11-18 04:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 15:00 ESTNewsNanoVibronix reports Q3 resultsN/A
2020-11-07 16:34 ESTFinancialsCompany financials have been released.Neutral
2020-10-17 01:39 ESTNewsNanoVibronix introduces PainsSield Plus for pain managementN/A
2020-10-09 16:13 ESTInsider TradeCHRISTOPHER M FASHEK has directly acquired 10,000 shares and currently holds 10,000 shares.Buy
2020-10-09 04:57 ESTNewsNanoVibronix trades high on regaining complianceN/A
2020-09-30 11:47 ESTNewsNanoVibronix soars on U.S. patent for PainShieldN/A
2020-09-26 13:29 ESTFinancialsCompany financials have been released.Neutral
2020-09-23 11:56 ESTNewsNanoVibronix rockets 100% on FDA authorization of UroShieldN/A
2020-09-23 11:54 ESTNewsNanoVibronix raises 'bought deal' offering to $1.8MN/A
2020-09-17 05:35 ESTFinancialsCompany financials have been released.Neutral
2020-08-25 15:05 ESTNewsNanoVibronix under pressure post $2.5M bought deal offeringN/A
2020-08-25 15:05 ESTNewsNanoVibronix raises bought deal offering to $3.25MN/A
2020-08-21 01:19 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:33 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 21:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 13:18 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:46 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 05:14 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 13:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-21 23:29 ESTNewsNanoVibronix files for $50M mixed shelfN/A
2020-07-09 09:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-08 17:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-07 14:28 ESTNewsNanoVibronix +61% on distributtion deal for PainShield deviceN/A

About NanoVibronix, Inc (NAOV):

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.

NAOV Quotes by TradingView

See Advanced Chart

General

  • Name NanoVibronix, Inc
  • Symbol NAOV
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 10
  • Fiscal Year EndDecember
  • IPO Date2017-06-27
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.nanovibronix.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 17.44
  • Price/Book (Most Recent Quarter) 8.7
  • Enterprise Value Revenue 40.72
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Operating Margin -713%
  • Return on Assets -77%
  • Return on Equity -164%
  • Revenue 620000
  • Earnings Per Share -$0.92
  • Revenue Per Share $0.08
  • Gross Profit 281000
  • Quarterly Earnings Growth 48.5%
View More

Highlights

  • Market Capitalization 28.45 million
  • EBITDA -5785000
  • Analyst Target Price $10.5
  • Book Value Per Share $0.22
View More

Share Statistics

  • Shares Outstanding 24.11 million
  • Shares Float 14.47 million
  • % Held by Insiders 765%
  • % Held by Institutions 7.17%
  • Shares Short 146818
  • Shares Short Prior Month 141632
  • Short Ratio 0.05
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta -0.16
  • 52 Week High $2.58
  • 52 Week Low $0.54
  • 50 Day Moving Average 1.24
  • 200 Day Moving Average 0.9
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

NanoVibronix, Inc (NAOV) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

NanoVibronix, Inc (NAOV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.10
2020-06-302020-09-30$269000-$0.10
2020-03-312020-06-30$N/A-$0.20
2019-12-312020-03-31$87000-$0.13
2019-09-302019-12-31$101000-$0.18-$0.207.85%
2019-06-302019-08-14$263000-$0.16-$0.2020%
2019-03-312019-04-15$79000-$0.18-$0.16-12.5%
2018-12-312019-02-27$54000-$0.18-$0.16-12.5%
2018-09-302018-11-14$54000-$0.21
2018-06-302018-08-14$132000-$0.13
2018-03-312018-05-15$77000-$0.12
2017-12-312018-03-29$70000-$0.26
2017-09-302017-11-14$65000-$0.35-$0.15-133.33%
2017-06-302017-08-14$52000-$0.19
2017-03-312017-05-15$52000-$0.37
2016-12-312017-03-31$49000-$0.25-$0.11-127.27%
2016-09-302016-11-14$61000-$0.13-$0.11-18.18%
2016-06-302016-08-15$62000-$0.13-$0.1931.58%
2016-03-312016-05-16$57000-$0.19
2015-12-312016-03-30$39000-$0.30
2015-09-302015-09-30$40000-$0.40
2015-06-302015-06-30$39000-$0.18

NanoVibronix, Inc (NAOV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

NanoVibronix, Inc (NAOV) Chart:

NanoVibronix, Inc (NAOV) News:

Below you will find a list of latest news for NanoVibronix, Inc (NAOV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

NanoVibronix, Inc (NAOV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

NanoVibronix, Inc (NAOV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-29NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1326706/000149315220012110/0001493152-20-012110-index.htm
2020-01-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326706/000000000020000720/0000000000-20-000720-index.htm
2020-07-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1326706/000000000020006893/0000000000-20-006893-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326706/000088458920000017/0000884589-20-000017-index.htm
2020-09-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326706/000091957420005706/0000919574-20-005706-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390019010727/0001213900-19-010727-index.htm
2019-06-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1326706/000121390019010729/0001213900-19-010729-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390019011522/0001213900-19-011522-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390019014211/0001213900-19-014211-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326706/000121390019015864/0001213900-19-015864-index.htm
2019-09-04PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1326706/000121390019017209/0001213900-19-017209-index.htm
2019-10-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326706/000121390019019389/0001213900-19-019389-index.htm
2019-10-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1326706/000121390019019393/0001213900-19-019393-index.htm
2019-11-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1326706/000121390019023543/0001213900-19-023543-index.htm
2019-11-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326706/000121390019024108/0001213900-19-024108-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390019024350/0001213900-19-024350-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000121390019025511/0001213900-19-025511-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000121390019025513/0001213900-19-025513-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000121390019025515/0001213900-19-025515-index.htm
2020-01-22S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326706/000121390020001484/0001213900-20-001484-index.htm
2020-01-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326706/000121390020001938/0001213900-20-001938-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390020007851/0001213900-20-007851-index.htm
2020-04-038-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390020008541/0001213900-20-008541-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390020008758/0001213900-20-008758-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000121390020010406/0001213900-20-010406-index.htm
2020-08-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326706/000121390020023984/0001213900-20-023984-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326706/000138713120001789/0001387131-20-001789-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220002495/0001493152-20-002495-index.htm
2020-05-14NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1326706/000149315220008851/0001493152-20-008851-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220008983/0001493152-20-008983-index.htm
2020-05-2010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326706/000149315220009519/0001493152-20-009519-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220010467/0001493152-20-010467-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220011017/0001493152-20-011017-index.htm
2020-06-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220011173/0001493152-20-011173-index.htm
2020-06-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1326706/000149315220011176/0001493152-20-011176-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220011864/0001493152-20-011864-index.htm
2020-06-29NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1326706/000149315220012110/0001493152-20-012110-index.htm
2020-07-06DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220012606/0001493152-20-012606-index.htm
2020-07-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220012689/0001493152-20-012689-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220012847/0001493152-20-012847-index.htm
2020-07-21S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326706/000149315220013650/0001493152-20-013650-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220014961/0001493152-20-014961-index.htm
2020-08-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326706/000149315220015046/0001493152-20-015046-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220015249/0001493152-20-015249-index.htm
2020-08-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1326706/000149315220015928/0001493152-20-015928-index.htm
2020-08-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016134/0001493152-20-016134-index.htm
2020-08-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220016309/0001493152-20-016309-index.htm
2020-08-2410-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220016624/0001493152-20-016624-index.htm
2020-08-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220016627/0001493152-20-016627-index.htm
2020-08-24FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016637/0001493152-20-016637-index.htm
2020-08-25FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016652/0001493152-20-016652-index.htm
2020-08-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220016771/0001493152-20-016771-index.htm
2020-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016774/0001493152-20-016774-index.htm
2020-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016885/0001493152-20-016885-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016907/0001493152-20-016907-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016908/0001493152-20-016908-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016962/0001493152-20-016962-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220016979/0001493152-20-016979-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018137/0001493152-20-018137-index.htm
2020-09-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220018191/0001493152-20-018191-index.htm
2020-09-23FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018195/0001493152-20-018195-index.htm
2020-09-23FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018205/0001493152-20-018205-index.htm
2020-09-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1326706/000149315220018276/0001493152-20-018276-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018277/0001493152-20-018277-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018953/0001493152-20-018953-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018955/0001493152-20-018955-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018957/0001493152-20-018957-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018959/0001493152-20-018959-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220018961/0001493152-20-018961-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220019127/0001493152-20-019127-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220019160/0001493152-20-019160-index.htm
2020-10-098-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220019188/0001493152-20-019188-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220019223/0001493152-20-019223-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220019573/0001493152-20-019573-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020489/0001493152-20-020489-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020490/0001493152-20-020490-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020491/0001493152-20-020491-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020492/0001493152-20-020492-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020493/0001493152-20-020493-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020509/0001493152-20-020509-index.htm
2020-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020531/0001493152-20-020531-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000149315220020701/0001493152-20-020701-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1326706/000161577419006755/0001615774-19-006755-index.htm
2019-05-02S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326706/000161577419006864/0001615774-19-006864-index.htm
2019-05-1310-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1326706/000161577419007616/0001615774-19-007616-index.htm
2019-05-13S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1326706/000161577419007671/0001615774-19-007671-index.htm
2019-05-16NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1326706/000161577419008020/0001615774-19-008020-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000161577419008100/0001615774-19-008100-index.htm
2019-05-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1326706/000161577419008162/0001615774-19-008162-index.htm
2019-05-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1326706/000161577419008192/0001615774-19-008192-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000161577419008254/0001615774-19-008254-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1326706/000161577419009203/0001615774-19-009203-index.htm
2019-05-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326706/999999999519001193/9999999995-19-001193-index.htm
2020-01-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326706/999999999520000188/9999999995-20-000188-index.htm
2020-08-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1326706/999999999520002099/9999999995-20-002099-index.htm

NanoVibronix, Inc (NAOV) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of NanoVibronix, Inc (NAOV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 765%
Institutional Ownership: 717%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-29CHRISTOPHER M FASHEKDirectorBuy10,000.000.797,887.0010,000.00https://www.sec.gov/Archives/edgar/data/1326706/000149315220019223/0001493152-20-019223-index.htm